SCORR Marketing, a global health science marketing and communications firm, in partnership with KNect365, a leading business intelligence, academic publishing, knowledge and events business, has released the results of its Report: Patient-Centricity in Clinical Trials.
The two companies conducted a survey to examine the perceptions, practices and future expectations of life science industry professionals regarding patient centricity in clinical development. The report focuses on how companies define and measure patient-centricity, solicit patient input and use technology in patient-centric initiatives.
“For the majority of these respondents, patient-centricity is a meaningful set of initiatives, not simply an industry buzzword,” said Anne-Marie Hess, Senior Strategic Adviser at SCORR Marketing.
“However, nearly one third said their companies do not solicit input from patients, so there is room for growth in understanding patient-centricity from the patient’s perspective.”
The research also includes information on how important respondents felt it was for their company to embrace patient centricity and their perceptions of their competitors’ emphasis on patient centricity.
“Technological advances have allowed companies to increase their patient-centric initiatives,” said Andrew Burrows, Digital Content Marketer at KNect365.
“This report identifies numerous ways in which companies can broaden their focus on patients.”
The patient centricity research report is available for download at www.scorrmarketing.com.